Approval for the lifestent flexstar and flexstar xl vascular stent system.  The device is indicated for improvement of luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 160 mm in length in the native superficial femoral artery (sfa) and proximal popliteal artery with reference vessel diameters ranging from 4.00 - 6.5 mm.